Research Beam added a report on “Down Syndrome Global Clinical Trials Review, H2, 2015” Enquiry about report: http://www.researchbeam.com/down-syndrome-global-clinical-trials-review-h2-2015-market/enquire-about-report

1. Down Syndrome Global
Clinical Trials Review, H2,
2015
TELEPHONE: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com

2. Report Overview
Down Syndrome Global Clinical Trials Review, H2, 2015 provides an overview of Down Syndrome clinical
trials scenario. This report provides top line data relating to the clinical trials on Down Syndrome. Report
includes an overview of trial numbers and their average enrollment in top countries conducted across the
globe. The report offers coverage of disease clinical trials by region, country (G7 & E7) , phase, trial status,
end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on
number of ongoing trials) .
Scope
The report provides a snapshot of the global clinical trials landscape
Report provides top level data related to the clinical trials by Region, Country (G7 & E7) , Trial Status, Trial
Phase, Sponsor Type and End point status
The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining
to the company
The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason
for unaccomplishment
The Report provides enrollment trends for the past five years
Report provides latest news for the past three months
Read More At : http://www.researchbeam.com/down-syndrome-global-clinical-trials-review-h2-2015-
market

3. Table of Content
Table of Contents
Table of Contents 2
List of Tables 3
List of Figures 4
Report Guidance 5
Clinical Trials by Region 6
Clinical Trials and Average Enrollment by Country 7
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9
Top Five Countries Contributing to Clinical Trials in Europe 10
Top Countries Contributing to Clinical Trials in North America 11
Top Countries Contributing to Clinical Trials in Middle East and Africa 12
Top Countries Contributing to Clinical Trials in Central and South America 13
Clinical Trials by G7 Countries: Proportion of Down Syndrome to Genetic Disorders Clinical Trials 14
Clinical Trials by Phase in G7 Countries 15
Clinical Trials in G7 Countries by Trial Status 16
Clinical Trials by E7 Countries: Proportion of Down Syndrome to Genetic Disorders Clinical Trials 17
Clinical Trials by Phase in E7 Countries 18
Clinical Trials in E7 Countries by Trial Status 19
Clinical Trials by Phase 20

4. Table of Content
In Progress Trials by Phase 21
Clinical Trials by Trial Status 22
Clinical Trials by End Point Status 23
Subjects Recruited Over a Period of Time 24
Clinical Trials by Sponsor Type 25
Prominent Sponsors 26
Top Companies Participating in Down Syndrome Therapeutics Clinical Trials 27
Prominent Drugs 28
Clinical Trial Profile Snapshots 29
Appendix 65
Abbreviations 65
Definitions 65
Research Methodology 66
Secondary Research 66
About GlobalData 67
Contact Us 67
Disclaimer 67
Source 68
Enquire At : http://www.researchbeam.com/down-syndrome-global-clinical-trials-review-h2-2015-
market/enquire-about-report

5. FOR MORE DETAILS
Visit us at :
Stay With Us:
http://www.researchbeam.com/down-syndrome-global-clinical-trials-review-h2-2015-market
5933 NE Win Sivers Drive,
#205, Portland, OR 97220
United States
TELEPHONE: +1 (800) 910-6452
DIRECT: +1 (503) 894-6022
E-MAIL: sales@researchbeam.com